🔎 Trials Near Me

Home › Neuroendocrine Tumors › Texas › Houston

Neuroendocrine Tumors clinical trials in Houston, TX

8 studies for Neuroendocrine Tumors are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

RecruitingPhase 3
  • Investigative Site, Houston
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06881992

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

RecruitingPhase 1
  • University of Texas - MD Anderson Cancer Center, Houston
24 Months – 18 Years · All sexes · Updated Sep 25, 2026 · NCT06441331

Project: Every Child for Younger Patients With Cancer

RecruitingObservational study
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
  • UT MD Anderson Cancer Center, Houston
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

RecruitingPhase 1/2
  • Crinetics Study Site, Houston
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT07129252

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

RecruitingPhase 1/2
  • MD Anderson Cancer Center, Houston
Ages 12 and older · All sexes · Updated May 27, 2026 · NCT03093116

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

RecruitingPhase 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Ages 18 and older · All sexes · Updated Dec 11, 2025 · NCT06943521

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Houston
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

RecruitingPhase 1
  • The University of Texas MD Anderson Cancer Center, Houston
Ages 18 and older · All sexes · Updated Sep 23, 2025 · NCT06805825

Neuroendocrine Tumors trials in other cities

Other studies in Houston

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.